Abstract
Background
The transcription factor CREB and the neurotrophin BDNF are important mood regulators due to their profound role in controlling the neuronal plasticity. Our previously published results from transgenic mice functionally lacking CREB in chosen neural populations have shown that BDNF upregulation evoked by chronic treatment with fluoxetine seems to be dependent on CREB residing exclusively in serotonergic neurons. To further elucidate this observation, we focused on the representative signaling cascades engaged in the regulation of BDNF production.
Methods
The study was carried out on mice lacking CREB in noradrenergic (Creb1DBHCre) or serotonergic (Creb1(TPH2CreERT2) neurons in CREM deficient background. Animals received fluoxetine (10 mg/kg, ip) or desipramine (20 mg/kg, ip) for 21 days. The expression of following proteins and their phosphorylated forms was assessed by Western blot: CREB, BDNF, CaMKIIα, ERK1/2.
Results
We showed that consistent with previously observed BDNF upregulation, chronic treatment with fluoxetine causes an increase in the pool of active CaMKIIα in w/t males, while in Creb1TPH2CreERT2 mutants, this effect ceased along with the observed decrease in ERK1/2 phosphorylation. These effects were region- and sex-specific. We did not observe a similar pattern of changes regarding the levels of BDNF expression and the CaMKIIα, ERK1/2 kinases in Creb1DBHCre mice exposed to desipramine. However, sex-dependent changes in the regulation of CaMKIIα and ERK1/2 activity were also observed.
Conclusions
Our study highlights the pivotal role of CREB in response to antidepressants, emphasizing different sex-dependent vulnerabilities to particular drugs and the important impact of CREM on the effects of CREB deletion.
Similar content being viewed by others
Abbreviations
- BDNF:
-
brain derived neurotrophic factor
- BCA:
-
bicinchoninic acid
- BSA:
-
bovine serum albumin
- CaMKII:
-
Ca2+/calmodulin-dependent protein kinase II
- CREB:
-
cyclic AMP response element binding protein
- CREM:
-
cyclic AMP response element modulator
- DBH:
-
dopamine β-hydroxylase
- DMI:
-
desipramine
- ERK:
-
extracellular signal-regulated kinase
- ER:
-
estrogen receptor
- ERT2:
-
mutant estrogen ligand-binding domain
- FLX:
-
fluoxetine
- GAPDH:
-
glyceraldehyde 3-phosphate dehydrogenase
- HIP:
-
hippocampus
- KO:
-
knock out
- LC:
-
locus coeruleus
- MAP:
-
mitogen-activated protein kinase
- PFC:
-
prefrontal cortex
- RIPA:
-
radioimmunopre- cipitation assay buffer
- RN:
-
raphe nuclei
- SAL:
-
saline
- SSRI:
-
selective serotonin reuptake inhibitor
- TPH:
-
tryptophan hydroxylase-2
- TrkB:
-
tropomyosin receptor kinase B
- TST:
-
tail suspension test.
References
Nair A, Vaidya VA. Cyclic AMP response element binding protein and brain-derived neurotrophic factor: molecules that modulate our mood? J Biosci 2006;31:423–34.
Ren X, Dwivedi Y, Mondal AC, Pandey GN. Cyclic-AMP response element binding protein (CREB) in the neutrophils of depressed patients. Psychiatry Res 2011;185:108–12.
Bjorkholm C, Monteggia LM. BDNF—a key transducer of antidepressant effects. Neuropharmacology 2016;102:72–9.
Dwivedi Y. Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 2010;42:87–96.
Blendy JA. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 2006;59:1144–50.
Hummler E, Cole TJ, Blendy JA, Ganss R, Aguzzi A, Schmid W, et al. Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proc Natl Acad Sci U S A 1994;91:5647–51.
Rafa-Zablocka K, Kreiner G, Baginska M, Kusmierczyk J, Parlato R, Nalepa I. Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test. Sci Rep 2017;7:13515.
Rafa-Zablocka K, Kreiner G, Baginska M, Nalepa I. Selective depletion of CREB in serotonergic neurons affects the upregulation of brain-derived neurotrophic factor evoked by chronic fluoxetine treatment. Front Neurosci 2018;12.
Ghosh A, Carnahan J, Greenberg ME. Requirement for BDNF in activity- dependent survival of cortical neurons. Science 1994;263:1618–23.
Cunha C, Brambilla R, Thomas KL. A simple role for BDNF in learning and memory? Front Mol Neurosci 2010;3:1.
Leal G, Comprido D, Duarte CB. BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology 2014;76(Pt C):639–56.
**ng J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996;273:959–63.
Segal RA. Selectivity in neurotrophin signaling: theme and variations. Ann Rev Neurosci. 2003;26:299–330.
Barnabe-Heider F, Miller FD. Endogenously produced neurotrophins regulate survival and differentiation of cortical progenitors via distinct signaling pathways. J Neurosci 2003;23:5149–60.
Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007;10:1089–93.
Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 2004;20:2580–90.
Parlato R, Rieker C, Turiault M, Tronche F, Schutz G. Survival of DA neurons is independent of CREM upregulation in absence of CREB. Genesis 2006;44:454–64.
Peck SC. Analysis of protein phosphorylation: methods and strategies for studying kinases and substrates. Plant J 2006;45:512–22.
Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995;15:7539–47.
Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 2002;22:3262–8.
Wang HT, Xu JP, Lazarovici P, Quirion RH, Zheng WH. cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia. Front Mol Neurosci 2018;11.
Andero R, Choi DC, Ressler KJ. BDNF-TrkB receptor regulation of distributed adult neural plasticity, memory formation, and psychiatric disorders. Prog Mol Biol Trans Sci. 2014;122:169–92.
Swulius MT, Waxham MN. Ca(2+)/calmodulin-dependent protein kinases. Cell Mol Life Sci 2008;65:2637–57.
Hanson PI, Meyer T, Stryer L, Schulman H. Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron 1994;12:943–56.
Barbiero VS, Giambelli R, Musazzi L, Tiraboschi E, Tardito D, Perez J, et al. Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology 2007;32:2511–9.
Celano E, Tiraboschi E, Consogno E, D’Urso G, Mbakop MP, Gennarelli M, et al. Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase II by psychotropic drugs. Biol Psychiatry 2003;53:442–9.
Martinez-Turrillas R, Del Rio J, Frechilla D. Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs. Biochem Biophys Res Commun 2007;353:750–5.
Yan X, Liu J, Ye Z, Huang J, He F, **ao W, et al. CaMKII-mediated CREB phosphorylation is involved in Ca2+-induced BDNF mRNA transcription and neurite outgrowth promoted by electrical stimulation. PLoS One 2016;11: e0162784.
Duman RS, Voleti B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 2012;35:47–56.
Fumagalli F, Molteni R, Calabrese F, Frasca A, Racagni G, Riva MA. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 2005;93:1551–60.
Di Benedetto B, Radecke J, Schmidt MV, Rupprecht R. Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex. Neuroscience 2013;232:161–8.
Alboni S, Benatti C, Capone G, Corsini D, Caggia F, Tascedda F, et al. Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats. Eur J Pharmacol 2010;643:180–7.
Qi X, Lin W, Li J, Li H, Wang W, Wang D, et al. Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress. Neurobiol Dis 2008;31:278–85.
Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 2007;61:661–70.
Borrow AP, Cameron NM. Estrogenic mediation of serotonergic and neurotrophic systems: implications for female mood disorders. Prog Neuropsychopharmacol Biol Psych 2014;54:13–25.
Bigos KL, Pollock BG, Stankevich BA, Bies RR. Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review. J Gend Specif Med 2009;6:522–43.
Thompson DS, Kirshner MA, Klug TL, Kastango KB, Pollock BG. A preliminary study of the effect of fluoxetine treatment on the 2: 16-alpha-hydroxyestrone ratio in young women. Ther Drug Monit 2003;25:125–8.
Donner N, Handa RJ. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009;163:705–18.
Suzuki H, Barros RP, Sugiyama N, Krishnan V, Yaden BC, Kim HJ, et al. Involvement of estrogen receptor beta in maintenance of serotonergic neurons of the dorsal raphe. Mol Psych 2013;18:674–80.
Amin Z, Canli T, Epperson CN. Effect of estrogen-serotonin interactions on mood and cognition. Beh Cog Neurosci Rev 2005;4:43–58.
Ye R, Wang QA, Tao C, Vishvanath L, Shao M, McDonald JG, et al. Impact of tamoxifen on adipocyte lineage tracing: inducer of adipogenesis and prolonged nuclear translocation of Cre recombinase. Mol Metab 2015;4:771–8.
Jacobsen JP, Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 2004;1024:183–92.
Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005;29:571–625.
Vinet J, Carra S, Blom JMC, Brunello N, Barden N, Tascedda F. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 2004;47:1062–9.
Kozisek ME, Middlemas D, Bylund DB. The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment. Neuropharmacology 2008;54:251–7.
Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res 2008;1211:37–43.
Monteggia LM, Barrot M, Powell CM, Berton O, Galanis V, Gemelli T, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 2004;101:10827–32.
Castren E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis 2017;97:119–26.
Dey A, Giblin PAH. Insights into macrophage heterogeneity and cytokineinduced neuroinflammation in major depressive disorder. Pharmaceuticals 2018;11.
Ortega-Martinez S. A new perspective on the role of the CREB family of transcription factors in memory consolidation via adult hippocampal neurogenesis. Front Mol Neurosci 2015;8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rafa-Zabłocka, K., Kreiner, G., Bagińska, M. et al. The influence of CaMKII and ERK phosphorylation on BDNF changes observed in mice selectively devoid of CREB in serotonergic or noradrenergic neurons. Pharmacol. Rep 71, 753–761 (2019). https://doi.org/10.1016/j.pharep.2019.04.008
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2019.04.008